Fang Cao

540 total citations
21 papers, 357 citations indexed

About

Fang Cao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fang Cao has authored 21 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fang Cao's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and MicroRNA in disease regulation (3 papers). Fang Cao is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and MicroRNA in disease regulation (3 papers). Fang Cao collaborates with scholars based in China, United States and Japan. Fang Cao's co-authors include Ileana M. Cristea, Yong Wei, Clifford P. Brangwynne, Lei Xia, Yibin Kang, Bin Jia, Wei Han, Dan Bracha, Christina J. DeCoste and Katelyn C. Cook and has published in prestigious journals such as PLoS ONE, Nature Cell Biology and Scientific Reports.

In The Last Decade

Fang Cao

19 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fang Cao China 13 234 110 49 29 26 21 357
Jun Su China 12 287 1.2× 113 1.0× 40 0.8× 24 0.8× 31 1.2× 21 407
Sandeep R. Bhave United States 7 209 0.9× 66 0.6× 68 1.4× 27 0.9× 21 0.8× 11 455
Peter Bazeley United States 10 333 1.4× 127 1.2× 28 0.6× 43 1.5× 44 1.7× 29 460
Medi Kori Türkiye 8 274 1.2× 110 1.0× 49 1.0× 22 0.8× 54 2.1× 24 433
Jianglong Lu China 12 179 0.8× 86 0.8× 37 0.8× 16 0.6× 23 0.9× 27 311
Hongjuan Cui China 11 305 1.3× 89 0.8× 59 1.2× 20 0.7× 40 1.5× 19 405
Di Lu China 10 174 0.7× 62 0.6× 31 0.6× 31 1.1× 26 1.0× 21 302
Michael Fletcher Germany 8 274 1.2× 93 0.8× 52 1.1× 10 0.3× 49 1.9× 12 410
Qiuting Feng China 12 286 1.2× 88 0.8× 31 0.6× 17 0.6× 21 0.8× 18 385

Countries citing papers authored by Fang Cao

Since Specialization
Citations

This map shows the geographic impact of Fang Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Cao more than expected).

Fields of papers citing papers by Fang Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Cao. The network helps show where Fang Cao may publish in the future.

Co-authorship network of co-authors of Fang Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Fang Cao. A scholar is included among the top collaborators of Fang Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang Cao. Fang Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Xu, Kedong, et al.. (2024). Mitochondrial dysfunction in pancreatic acinar cells: mechanisms and therapeutic strategies in acute pancreatitis. Frontiers in Immunology. 15. 1503087–1503087. 6 indexed citations
4.
Cao, Fang, et al.. (2024). The relationship between diabetes and the dementia risk: a meta-analysis. Diabetology & Metabolic Syndrome. 16(1). 24 indexed citations
5.
Xia, Lei, et al.. (2023). Afzelin induces immunogenic cell death against lung cancer by targeting NQO2. BMC Complementary Medicine and Therapies. 23(1). 381–381. 16 indexed citations
6.
Esposito, Mark, Fang Cao, Katelyn C. Cook, et al.. (2021). TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis. Nature Cell Biology. 23(3). 257–267. 90 indexed citations
7.
Cao, Fang, et al.. (2021). Circulating long noncoding RNAs as potential biomarkers for stomach cancer: a systematic review and meta-analysis. World Journal of Surgical Oncology. 19(1). 89–89. 13 indexed citations
8.
Liu, Yun, Hao Zhuang, Fang Cao, et al.. (2021). Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway. Cell Death and Disease. 12(3). 278–278. 23 indexed citations
9.
Xu, Jianhao, Fang Cao, Fang Chen, et al.. (2021). Diagnostic Role of Long Non-Coding RNAs in Breast Cancer: a Systematic Review and Meta-Analysis. Clinical Laboratory. 67(03/2021). 4 indexed citations
10.
11.
Zhang, Chuanlong, et al.. (2020). Prognostic Value of EZH2 in Non‐Small‐Cell Lung Cancers: A Meta‐Analysis and Bioinformatics Analysis. BioMed Research International. 2020(1). 2380124–2380124. 12 indexed citations
12.
Han, Wei, Cong Zhang, Minghui Zhou, et al.. (2020). Roles of eIF3m in the tumorigenesis of triple negative breast cancer. Cancer Cell International. 20(1). 141–141. 12 indexed citations
13.
Jia, Bin, Lei Xia, & Fang Cao. (2018). The role of miR-766-5p in cell migration and invasion in colorectal cancer. Experimental and Therapeutic Medicine. 15(3). 2569–2574. 19 indexed citations
14.
Cao, Fang, Cong Zhang, Wei Han, et al.. (2017). p-Akt as a potential poor prognostic factor for gastric cancer: a systematic review and meta-analysis. Oncotarget. 8(35). 59878–59888. 16 indexed citations
15.
Han, Wei, et al.. (2016). Prognostic and clinicopathological value of NM23 expression in patients with breast cancer: A systematic review and meta-analysis. Current Problems in Cancer. 41(1). 80–93. 7 indexed citations
16.
Han, Wei, Fang Cao, Min‐Bin Chen, et al.. (2016). Prognostic Value of NME1 (NM23-H1) in Patients with Digestive System Neoplasms: A Systematic Review and Meta-Analysis. PLoS ONE. 11(8). e0160547–e0160547. 12 indexed citations
17.
Mi, Ruifang, Chunxiao Pan, Liqiang Song, et al.. (2012). Fusion between tumor cells enhances melanoma metastatic potential. Journal of Cancer Research and Clinical Oncology. 138(10). 1651–1658. 13 indexed citations
18.
Taguchi, Akihiko, Pengxiang Zhu, Fang Cao, et al.. (2010). Reduced Ischemic Brain Injury by Partial Rejuvenation of Bone Marrow Cells in Aged Rats. Journal of Cerebral Blood Flow & Metabolism. 31(3). 855–867. 18 indexed citations
19.
Wei, Qinjun, et al.. (2007). Inhibition of cell proliferation by siRNA targeting hPRLR in breast cancer MCF-7 cell line. 21(6). 372–376. 2 indexed citations
20.
Sakanaka, Masahiro, Pengxiang Zhu, Bo Zhang, et al.. (2007). Intravenous Infusion of Dihydroginsenoside Rb1 Prevents Compressive Spinal Cord Injury and Ischemic Brain Damage through Upregulation of VEGF and Bcl-x L. Journal of Neurotrauma. 24(6). 1037–1054. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026